Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

Margaret May*, Mark Gompels, Valerie Delpech, Kholoud Porter, Frank Post, Margaret Johnson, David Dunn, Adrian Palfreeman, Richard Gilson, Brian Gazzard, Teresa Hill, John Walsh, Martin Fisher, Chloe Orkin, Jonathan Ainsworth, Loveleen Bansi, Andrew Phillips, Clifford Leen, Mark Nelson, Jane AndersonCaroline Sabin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

233 Citations (Scopus)

Abstract

Objectives: To estimate life expectancy for people with HIV undergoing treatment compared with life expectancy in the general population and to assess the impact on life expectancy of late treatment, defined as CD4 count <200 cells/mm3 at start of antiretroviral therapy. Design: Cohort study. Setting: Outpatient HIV clinics throughout the United Kingdom. Population: Adult patients from the UK Collaborative HIV Cohort (UK CHIC) Study with CD4 count ≤350 cells/mm3 at start of antiretroviral therapy in 1996-2008. Main outcome measures: Life expectancy at the exact age of 20 (the average additional years that will be lived by a person after age 20), according to the cross sectional age specific mortality rates during the study period. Results: 1248 of 17 661 eligible patients died during 91 203 person years' follow-up. Life expectancy (standard error) at exact age 20 increased from 30.0 (1.2) to 45.8 (1.7) years from 1996-9 to 2006-8. Life expectancy was 39.5 (0.45) for male patients and 50.2 (0.45) years for female patients compared with 57.8 and 61.6 years for men and women in the general population (1996-2006). Starting antiretroviral therapy later than guidelines suggest resulted in up to 15 years' loss of life: at age 20, life expectancy was 37.9 (1.3), 41.0 (2.2), and 53.4 (1.2) years in those starting antiretroviral therapy with CD4 count <100, 100-199, and 200-350 cells/mm3, respectively. Conclusions: Life expectancy in people treated for HIV infection has increased by over 15 years during 1996-2008, but is still about 13 years less than that of the UK population. The higher life expectancy in women is magnified in those with HIV. Earlier diagnosis and subsequent timely treatment with antiretroviral therapy might increase life expectancy.

Original languageEnglish
Article numberd6016
JournalBritish Medical Journal
Volume343
Issue number7829
DOIs
Publication statusPublished - 29 Oct 2011

Fingerprint

Dive into the research topics of 'Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study'. Together they form a unique fingerprint.

Cite this